Fundacion Investigación Hospital General Universitario De Valencia

Consorcio Hospital General Universitario and its Research Foundation (FIHGUV) are located in Valencia (Spain) and dedicated to improving and protecting the health and well-being of our citizens, a total population of 800,000 people. Therefore FIHGUV actively participates in international partnerships and collaborations, through H2020 and other European calls. Consorcio Hospital General Universitario de Valencia (FIHGUV) in particular uses its resources to enhance interdisciplinary and interprofessional research on global health issues. Hereby the International Project Office of FIHGUV provides health research coordination for optimal impact of innovation processes and effective knowledge translation.

In STOPSTORM both the Radiotherapy Oncology Department and Cardiology Department of FIHGUV are involved. The Radiotherapy Oncology Department has experienced with SRBT treatment since 2014, which is applied in primary lung and prostate tumors, and lung, liver, lymph node and bone metastases. The treatment team for STOPSTORM will consist of both radiophysicists and radiation oncologists.

The Cardiology Department has been pioneering in electrophysiology (1995), VT ablation (1996), pulmonary vein ablation (1999) and the use of electromagnetic mapping (1998). The department has the required facilities and expertise to perform STAR treatment and views the treatment as having great potential.